Host immune system – indirect activation via antigen presentation

Host immune system – indirect activation via antigen presentation refers to the physiological process by which the adaptive immune system is alerted to the presence of pathogens or malignant cells through the mediation of professional antigen-presenting cells (APCs) (Gaudino & Kumar, StatPearls 2023). This mechanism involves the internal processing of antigens into peptide fragments, which are then loaded onto Major Histocompatibility Complex (MHC) molecules and displayed on the cell surface (Roche & Furuta, Nature Reviews Immunology 2015). Recognition of these MHC-peptide complexes by T-cell receptors (TCRs) is a fundamental requirement for the initiation of a specific immune response (Blum et al., Annual Review of Immunology 2013). In clinical practice, this pathway is the primary target of vaccines and certain immunotherapies, which aim to enhance the presentation of specific antigens to prime T-cell activity (Mellman et al., Nature 2011). Because this entry describes a broad biological pathway involving multiple cell types and molecular interactions rather than a single protein or receptor, it is classified as a mechanism of action rather than a discrete therapeutic target (ChEMBL Database). Consequently, drugs associated with this mechanism typically act as agonists or delivery vehicles that facilitate the natural antigen-presentation cycle to achieve a therapeutic effect (Abbas et al., Cellular and Molecular Immunology 2021). Notable examples include mRNA vaccines that provide the genetic template for antigen production and adjuvants that stimulate APC maturation (Pardi et al., Nature Reviews Drug Discovery 2018). This indirect approach allows for a broad and durable immune response compared to direct-acting agents (Sallusto et al., Annual Review of Immunology 2004).

Other names

Antigen presentation pathwayIndirect immune activationAPC-mediated T-cell activationAntigen processing and presentation

Stimulation of professional antigen-presenting cells to process and display antigens on MHC molecules, thereby activating the adaptive immune response.